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A Comparative Study of Monoclonal Antibodies (Mabs) Purified from Cell Culture 
Supernatant on EDTPA-Modified Zirconia Beads and Protein A-Hyper D Support 
 
Abstract: 
Colloidal zirconia was spray dried to yield zirconia particles, which were further modified 
with N, N, N0, N0- Ethylenediamine tetra methylenephosphonic acid (EDTPA) to yield a sup-
port for use in bioseparations. EDTPA modified zirconia particles will be further referred to as, 
r_PEZ. Cell culture supernatants rich in monoclonal antibody (Mab) subtypes IgG1, IgG2a, 
IgG2b, and IgG3 were chromatographed on a r_PEZ column, and on a protein A-hyper D col-
umn that was purchased commercially. All Mab subtypes bound to r_PEZ and process yields 
in the range of 88 to 99% were obtained. The purity of the Mab products were ascertained by 
gel lectrophoretic analysis and were estimated to be greater than 95%. The purified Mab prod-
ucts obtained from r_PEZ and protein A columns were compared to the reference Mab stan-
dard in biological and enzymatic assays. The value of the dissociation constant (Kd) was found 
to be comparable and was in the range to that obtained with reference Mab standard 
(0.231+0.03 M). In addition, Mabs purified with r_PEZ had the same deglycosylation profile as 
the reference Mab standard. Thus, it appears that the r_PEZ purified Mab is similar in activity 
to Mab purified with a protein A support and in addition, the zirconia surface does not ad-
versely impact the activity of the purified Mab. 
 
INTRODUCTION 
The importance of immunoglobulins (Ig’s) has been well researched and docu-
mented.[1] The unique specificity that an antibody displays for an antigen makes it an invalu-
able tool in diagnostics[2,3] as probes for fine structural analysis,[4,5] in histological examina-
tion,[6] and in immunotherapy.[7] Purified immunoglobulin products have been used for medi-
cal treatment in patients with inadequate Ig levels.[8] As the discovery of new medical and di-
agnostic uses for immunoglobulins arise, an increased need for medicalgrade Ig’s will continue 
to fuel advances in the area of Ig separation. There is a demand in the current market to de-
sign and develop methodologies for the purification of human globulin from plasma or from ge-
netically engineered sources. Purification schemes for Ig’s include precipitation with ammo-
nium sulfate, gel filtration chromatography, ion-exchange chromatography,[ 9] thiophilic chro-
matography,[10] and affinity separations using immobilized protein-A.[4,11,12] Protein A affin-
ity chromatography is a technique that has long been used for IgG isolation[13] and recently, 
protein G with a broader range of specificity has also been used in IgG isolation. The usage of 
both protein A and protein G in affinity chromatography is negatively impacted by the harsh 
elution conditions necessary for the reverse binding reaction to take place. In addition, the use 
of both protein A and protein G as affinity supports in chromatographic columns poses special 
challenges regarding regeneration and sanitation.[14] Also, a negative consequence of using 
this method is the leakage of immobilized protein A and protein G (whole protein and frag-
ments) that results in the contamination of the eluted immunoglobulins.[15] This is detrimental 
because protein A has been linked with toxicity in both animals and humans.[16] Although pro-
tein A mimetic ligands have shown promise, ligand leakage and column regeneration are still 
sources of potential shortcomings. Although protein A affinity chromatography is a popular step 
in protein purifications, the need for less expensive, more stable alternatives to this technique 
has prompted many researchers to turn their attentions to the development of synthetic 
ligands. The techniques developed using pseudo- A. bioaffinity ligands have proven to avoid 
the risks associated with toxicities in elution fractions due to ligand leakage. Additionally, these 
ligands typically provide for a mild elution environment, thereby retaining immunological prop-
erties of the protein, have broader immunoglobulin specificity, and are more stable in chroma-
tographic systems in comparison to ligands such as protein A and G.[17] The use of histidyl 
and thiophilic ligands are limited due to their lack of specificity and selectivity. Metal chelate 
interaction chromatography using Cuþþ-chelate gel has been studied for the separation of Ig 
from blood serum and plasma.[18,19] However, concern of metal ligand leakage in the  eluant 
presents a drawback. Additionally, the strength of bonding of the metal ion to the support, so 
that residual affinity for proteins remains, is often difficult to achieve.[20] The preparation of al-
ternative stationary phase supports is an important area that aims to develop new support ma-
terials that offer novel selectivities or overcome the shortcomings of existing supports. Hence, 
there was an interest to develop adsorbents that operated based on physiochemical affinities 
or on mixed mode synthetic chemistries coupled with engineered matrices.[28] The develop-
ment of EDTPA modified zirconia as a stationary phase material  is an example where both 
aspects may be achieved. Studies have established the usefulness of r_PEZ as a chroma-
tographic stationary phase[21 – 27] in HPLC applications and in the efficient purification of an-
tibodies.[29] The aim of this study is to compare the activities of antibody products purified on 
r_PEZ and protein A_hyper D support. The impact, if any, of the zirconiabased stationary 
phase on the activities of antibodies will be evaluated. 
 
EXPERIMENTAL 
 
Reagents 
 
All chemicals were of analytical grade or better. Sodium chloride was purchased from Fischer 
Scientific (Hanover Park, IL, USA). N, N, N0, N0- Ethylenediamine tetra methylenephosphonic 
acid (EDTPA) was purchased from TCI America (Portland, OR, USA). Bovine serum albumin 
(BSA), pure human immunoglobulin G (HIgG), all horseradish peroxidase conjugated anti-
immunoglobulins used for ELISA, and human serum albumin (HSA) were obtained from Sigma 
Chemical Company (St. Louis, MO, USA). All  proteins were used without further purification. 
Cell culture supernatant rich in Mab subclasses IgG1, IgG2a, IgG2b, and IgG3 was purchased 
from SOBIO (Southern Biotechnology Institute, Birmingham, AL). Pure Mab standards (sub-
classes) were also purchased from SOBIO. Rabbit anti-human Protein C (P-4680), goat anti-
mouse IgG (A-4416), and calcium chloride (CaCl2) were purchased from Sigma (St. Louis, 
MO). Purified human protein C (hPC-239F) was purchased from American A Comparative 
Study of Monoclonal Antibodies 473 Diagnostica Inc. (Greenwich, CT). O-Phenylenediamine-
2HCl (OPD) tablets were purchased from Abbot Laboratories (Chicago, IL). Reference Mab 
was provided as a generous gift by Dr. William Velander (Virginia Tech, Blacksburg, VA). 
PNGase F Kit was obtained from New England BioLab Inc. (Beverly, MA). NuPage 4–12% Bis-
Tris gels were purchased from Invitrogen (Carlsbad, CA). Gelcode for staining was obtained 
from Pierce (Rockford, IL). Immulon II microtiter plates were purchased from Fisher Scientific 
(Hanover Park, IL, USA). Affinity purified goat anti-mouse  (whole molecule) immunoglobulins 
and goat anti-mouse immunoglobulins conjugated to horseradish peroxidase (HRP) were pur-
chased from Sigma Chemical Company (St. Louis, MO, USA). A GenesysTM 5 model from 
Spectronic Instruments UV-visible spectrophotometer (Rochester, NY, USA) was used to re-
cord the adsorption measurements. A bench top microcentrifuge (Eppendorf Centrifuge 
5415C) was used to sediment the r_PEZ particles for batch experiments. Chromatography. 
EDTPA modified particles were packed in 20 cm _ 1.0 cm (i.d.) cm and provided by Zirchrom, 
Inc. The chromatographic system used was a HPLC system using a Spectroflow 783 detector 
at 280 nm and an isocratic pump from Chromtech (Apple Valley, MN). For separation and iso-
lation of IgG1,2a,2b,3 from the cell culture supernatant, a protocol similar to that described 
elsewhere was adopted.[27] In a separate experiment, 2.0mL protein A immobilized on hyper 
D support was packed into a Pharmacia column (1.0 cm _ 10.0 cm) and cell culture super-
natants were chromatographed according to the manufacturer’s instructions. In a typical appli-
cation, 1mL of supernatant was diluted with 1.0mL of 0.5M sodium citrate buffer at pH 8.4 
(LB1). Feed was filtered using a Millipore 0.45 microns membrane filter and loaded on to the 
column at a linear velocity of 1.25 cm/min. Loosely bound proteins were washed with LB1. The 
elution of the bound Mab was effected with 0.5% acetic acid. The pH of the elution fraction was 
immediately raised to 7.0 with 1M Tris-base. All chromatographic fractions were saved and 
analyzed for total protein content at OD 280 nm, Mab content by specific ELISA assays and 
electrophoretic analysis. SDS-PAGE Analysis and Western Blot SDS-PAGE analysis under 
non-reducing and reducing conditions were performed using Novex electrophoresis system. 
Gels were stained with Gelcode to visualize the protein bands.[30] Western blots were per-
formed with nitrocellulose membranes using standard procedures and DAB substrate was 
used to visualize the bands.  Enzymatic Deglycosyation of Mab Standard and purified Mab of 
100 mL from r_PEZ column and protein A-hyper D at 50mg/mL were denatured with 5mL of 
10X denaturing buffer for 5 min at 958C. Upon cooling to room temperature, 6mL of 10X G7 
buffer and 6 mL of 10% NP-40 was added. Of the enzyme, 3mL were added to each reaction 
tube and incubated for 1 hr at 378C. The deglycosylated proteins were analyzed by western 
blotting. Estimation of Kd Costar microtiter plates were coated with 100 mL per well of 0.5 
mg/mL of pure hPC for 24 hr at 48C. Plates were washed three to four times with TBS/0.2% 
Tween-20 buffer and blocked with 200 uL of TBS/0.1% BSA buffer for 60 min at room tem-
perature. Mabs (Mab purified with r-PEZ, Mab purified with protein A, Mab provided by Dr. 
Subramanian) at 40 and 20 ng/mL were incubated with pure hPC at various Ag/Ab ratios (40 to 
0.078 mol/mol) in TBS/0.1% BSA-25mM EDTA buffer for 24 hr at 48C. Triplicate application of 
100 mL of Mab:hPC dilutions were pipetted into the coated plates. The plates were incubated 
for 8 minutes at RT. After washing the plates three times with TBS/Tween buffer, the complex 
was detected by addition of 1:1000th diluted goat anti-mouse HRP conjugate (A-4416) and in-
cubated for 1 hr at 378C. The bound chromophorei was detected with OPD, and the reaction 
was stopped with 3N H2SO4. Absorbance was measured at 490 nm.  
 
RESULTS 
 
Expression Level and Purification Yields Experiments to characterize the performance 
of r_PEZ were performed with commercially available, pure, Mab subclasses. In order to iden-
tify the elution and retention profiles pure Mab were chromatographed on the EDTPA modified 
zirconia column. As judged by the chromatographic trace at 280 nm, most of the Mab was re-
tained on the matrix and was eluted at five column volumes. A model solution, which mimics 
the target stream  from which Mabs would be isolated (i.e., a cell culture supernatant), was 
produced by mixing BSA and Mab to gauge the ability of the modified zirconia phase to effi-
ciently separate the Mab from other contaminating proteins present in the cell culture super-
natant. No retention of either BSA on the matrix was observed, as judged by a large peak 
eluting at the dead volume of the column (data not shown). The Mab was well retained on the 
EDTPA modified zirconia column and eluted at 5 column volumes. A Comparative Study of 
Monoclonal Antibodies. Chromatographic profiles with similar characteristics to one described 
elsewhere[27] were obtained for the isolation of Mab from the cell culture supernatant and a 
representative profile is shown in Figure 1, panel B. A representative  chromatographic profile 
for the isolation of Mab from cell culture supernatant on commercially purchased protein-A col-
umn is shown in Figure 1, panel A. The profile of the elution peak on a r_PEZ column was 
sharp and was approximately between 4 to 6 column volumes. In our experience, the elution 
peak on an immobilized protein-A column was asymmetric with shoulders and tailing. No visi-
ble peaks were observed in the regeneration step in either of the columns tested. Table 1 
summarizes the total protein recovery and Mab yield in the eluate fractions for both r_PEZ and 
protein-hyper D columns. The Mab concentration in different chromatographic fractions in each 
individual run was estimated by the ELISA assays. The percent yield of Mab in the eluate frac-
tion was determined as a ratio of the total Mab in the eluate fraction to the total Mab challenge. 
In most cases, total Mab recoveries of 80–99% were obtained. The r_PEZ column runs shown 
in Table 1 had Mab yields (based on ELISA) of in the range of 60% to 93%, while the protein 
A-hyper D column runs had Mab yields of in the range of 73% to 100%, respectively, with little 
 
or no detectable Mab in column fall through and wash fractions. 
igure 1. Separation of Mab on various chromatography columns. (A) Protein A on hyper-D and (B) 
at OD 280 nm, Mab content by specific ELISA assays and electrophoretic analysis.  
F
EDTPA modified zirconia. EDTPA modified particles were packed in 15 cm _ 1.0 cm (i.d.) cm and pro-
vided by Zirchrom, Inc. The chromatographic system  used was a HPLC system using a spectroflow 
783 detector at 280 nm and an isocratic pump from Chromtech (Apple Valley, MN). Diluted Mab-rich 
supernatant was loaded dynamically, loosely bound proteins were washed, and bound Mab was eluted 
with 1M NaCl. All chromatographic operations were preformed at a linear flow rate of 6.37mL/min. Pro-
tein A immobilized on hyper D support was packed into a Pharmacia  according to the manufacturer’s 
instructions. Loosely bound proteins were washed with loading buffer and the bound Mab was eluted 
with 0.5% acetic acid. All chromatographic fractions were saved and analyzed for total protein content 
Figure 2 shows SDS-PAGE gel of the purified fractions from a typical ch
separation. Chromatographic fractions from runs in Table 1 were selected
romatographic 
 for electrophoretic 
lications of pure 
Mab a
analysis. Lane 1 shows a molecular weight ladder. Lanes 2 and 3 show app
nd  BSA at a total protein level of 2 mgs, respectively. Lanes 4 show a representative 
sample the feed cell culture supernatant. Lanes 5 and 6 show an application of IgG1-Mab puri-
fied with r_PEZ column, at a total protein level of 3 mgs. Lanes 7 and 8 show an application of 
Mab purified with protein-A column, at a total protein level of 3mgs. The eluate fraction from 
both protein A hyper D column and r_PEZ gave a band around 150 kDa similar to the pure 
Mab in Lane 3. In addition to the major Mab band at 150 kDa, a minor band at 56 kDa account-
ing for less than 2% of the area obtained by digital image processing was observed. Lane 9 
and 10 show an application of column fall through at a total protein level of 3 mgs. The purity of 
the Mab in the eluate  fraction (Lanes 4 and 5) is estimated to be greater than 98%, respec-
tively, by digital image processing. Similar electrophoretic patterns were obtained with the frac-
tions from other runs listed in Table 1 (data not shown).  
turing (reduced) conditions. Chromatographic fractions fr
Figure 3 shows a SDS-PAGE gel of the starting cell culture supernatant (feed) and the 
purified fractions from a typical chromatographic separation on a r_PEZ column, under dena-
om Table 1 were selected for electro-
phoretic analysis. Lane 1 shows a molecular weight ladder. Lanes 2 and 3 show application of 
pure BSA and Mab at a total protein level of 5mgs, respectively. Lanes 4 to 7 show an applica-
tion of the elution fraction from cell culture supernatants rich in IgG1, IgG2a, IgG2b, and IgG3, 
respectively, at a total protein level of 7mgs. Lane 9 shows the fall through fraction from a typi-
cal run at a total protein level of 10mgs. The fall through fraction gave a band around 56kDa 
similar to the pure BSA in Lane 2. Lane 10 shows the feed fraction to the column for a typical 
run, at a total protein level of 10mgs. The eluate fraction gave two bands around 55 and 
24kDa, representative of the heavy and the light chain of Mab.  
not shown). Lane 9 shows a representative fall through fraction 
As expected, the heavy chains of Mab subspecies have different mobility as
by their migration patterns, and this arises from the difference in the glycosy
migration pattern was compared to that of pure Mab standards and found to be identical (data 
 evidenced 
ation levels. The 
at a total protein level of 3mgs. 
The fall through fraction gave a band around 56kDa similar to the pure BSA in Lane 2. Figure 4 
shows the electrophoretic mobility of Mabs purified using different matrices upon treatment 
with N-glycosidase F. Lane 1, 3, and 5 Figure 2. Sodium dodecylsulfate (0.1%)-polyacrylamide 
gel (4–12% gradient) electrophoresis of Mab’s purified using r-PEZ and protein A-HD. Lane 1 
shows a molecular weight ladder. Lanes 2 and 3 show applications of pure Mab and BSA. 
Lanes 4 shows a representative sample of the feed cell culture supernatant. Lanes 5 and 6 
show an application of IgG1-Mab purified with r_PEZ column. Lanes 7 and 8 show an applica-
tion of Mab purified with protein-A column. Lane 9 and 10 show an application of column fall 
through show a 100 ng application of Mab purified from r_PEZ, protein A-hyper D, and Mab-
reference standard, respectively. Lane 2, 4, and 6 show deglycosylated  Mab and the apparent 
faster mobility of the heavy chain due to removal of N-linked sugars is readily visible. No shift 
in the apparent  mobility of the light chain of the Mab was observed, which is consistent with 
the absence of glycosylation of the light chain. Upon deglycosylation, heavy chains of all Mab 
samples had a similar shift in mobility. 
 
 
 
 
 
 
 We have used the ELISA based method as described in detail elsewhere[35] to deter-
mine the binding kinetics and Kd. The method used in this study is based on the detection of 
the free Mab in the reaction mixture by an indirect ELISA procedure, after the Mab and the an-
tigen reach equilibrium in solution. The underlying assumption is that the interaction between 
unbou  immobilized antigen (hPC in this case) does not differ significantly from 
the eq
ange of pore sizes, nearly ideal pore structure, and 
ersatility of the silanization chemistry. However, the dissolution of silica in aqueous mobile 
y recognized and documented, and is also prone to acid-catalyzed hydrolysis of 
e siloxane bonds below pH 2 and dissolution above pH of 8.0 by alkali attack.[32 – 34] Thus, 
nd Mab and the
uilibrium attained between both in solution. Table 2 shows the value of the disassocia-
tion constant (Kd) obtained for Mabs purified with r-PEZ and protein A-HD, and a reference 
Mab sample. Previous research has documented and characterized the affinity of the Mab 
used in this study,  and hPC the parent antigen.[31] Disassociation constant (Kd) values of 
0.236+0.05 nM and 0.262+0.03nM were obtained for Mab purified using r_PEZ column and a 
protein-A hyper D column, respectively. A Kd value of 0.262+0.03 nM was obtained for Mab 
reference standard. Comparable values of Kd suggest that the Mab purified via the r_PEZ col-
umn has  similar activity to Mab reference standard, and the antigenic property for the Mab 
was not adversely impacted either by the zirconia matrix itself or the reagents and buffer em-
ployed in the chromatographic separation. 
 
DISCUSSION 
 
The popularity of silica as a chromatographic support results from the cumulative impact of its 
mechanical strength, availability in a wide r
v
phases is widel
th
the preparation of alternative stationary phase supports is an important area that aims to de-
velop new support materials that offer novel selectivities, or to overcome the shortcomings of 
silica, alumina, and polymeric supports. The development of zirconia as a stationary phase 
material is an example where both aspects may be achieved.  
basic solutions.[23] The surface of bare zirconia is populated w
Zirconia surface has a unique surface chemistry and offers many possibilities for use in 
chromatography; it can be used as a bare support, it can be dynamically
phates and EDTPA), it may be coated with polymers or with inorganic layers
high density and excellent thermal and chemical stability provide several advantages over tra-
ditional silica or polymeric supports. Zirconia particles are extremely stable in both acidic and 
 modified (i.e., phos-
. Additionally, its 
ith 4 to 5 millimoles per square 
millimeter (mmoles/mm2) of Lewis acid sites, which are strong electrophiles and promote irre-
versible adsorption.[21,23] Therefore, surface modification of  zirconia to titrate or neutralize 
the Lewis acid sites is essential before zirconia surface can be rendered useful as a support 
for chromatographic applications. Unless these electrophilic sites are charge titrated, zirconia 
particles undergo non-reversible protein adsorption and exhibit severe tailing. The great affinity 
of zirconia for phosphate, and the low solubility of zirconium phosphate in aqueous media, 
made the intentional modification of zirconia with EDTPA an attractive concept. EDTPA is a 
special chelator that renders zirconia Lewis acid deactivated (Figure 5). To overcome these 
effects, we have modified the zirconia surface with EDTPA and we have ensured that the buff-
ers employed also contain 4mM EDTPA. Since EDTPA coating is adsorbed and not chemically 
bonded, we sought to evaluate the stability of EDTPA-modified zirconia surface under a wide 
variety of pH and buffer conditions. Our results indicate that EDTP. A modified zirconia is sta-
ble from pH 1 to pH 10, and the EDTPA does not desorb from the surface. In these experi-
ments, EDTPA-zirconia columns were flushed with 7000 column volumes of a pH 10 buffer 
and a pH 1 buffer, respectively, as separate experiments. Test solutes were periodically in-
jected and the retention, selectivity, and efficiency were monitored. The selectivities and effi-
ciencies of test solutes were nearly the same before and after the high pH and low pH expo-
sure (Figure 6). Retention values of test solutes decreased by less than 3% to 4%. Thus, it is 
surprisingly stable.  
The underlying rationale for this study is that a fundamental understanding of the nature 
of interactions between EDTPA modified zirconia and IgG, and of the impact of the chemistry 
and property of the base matrix on the biological properties of the purified proteins, will enable 
the development of robust and scalable alternate sorbents for use in preparative biosepara-
tions. The underlying hypothesis was that zirconia being a charge-dense  material Figure 5. 
Schematic of zirconia surface and N, N, N0, N0- Ethylenediamine tetra methylenephosphonic 
acid (EDTPA) may cause protein to denature upon retention. Proteins retained on immobilized 
metal affinity chromatographic supports (IMAC) have been shown to loose biological activity 
and, in some cases, have been denatured.  
 
 
In the absence of a spacer arm, it is conceivable that the retained Mab is in close prox-
imity to the zirconia surface and subject to charge-induced denaturations. Hence, the activity of 
Mab products obtained from separation on a r_PEZ column and protein A-hyper D column 
were assayed for biological activity. We have used deglycosylation profile and the value of the 
Kd as identifiable markers. Denaturation of the Mab has shown to manifest itself in the loss of 
antigenicity, leading to an altered value of Kd. Our study has shown that these parameter are 
unaffected by either the zirconia matrix itself or the process conditions used in separation. In 
conclusion, our present study has shown that the zirconia surface has no negative impact on 
the properties of purified Mab. In conjunction with our previous studies that have been reported 
elsewhere, EDTPA modified zirconia columns can now be used in the preparative scale sepa-
rations of immunoglobulins. In addition, other chemistries could be exploited to produce 
phases with different retention mechanisms. Once EDTPA has been adsorbed, it may be pos-
sible to produce phases exhibiting different selectivities. These postderivatization procedures 
could include cross linking with diiodoalkanes to increase both phase stability and alter the se-
lectivity of the support. 
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